FDA opens dialogue on nanotechnology regulation

According to FDA Commissioner Margaret A. Hamburg:

Our goal is to regulate these products using the best possible science. Understanding nanotechnology remains a top priority within the agency’s regulatory science initiative and, in doing so, we will be prepared to usher science, public health, and FDA into a new, more innovative era.